Incyte's frontMIND trial found Tafasitamab (Monjuvi/Minjuvi) combo significantly prolongs progression-free survival in ...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer ...
Strategy pulled 411.5 BTC from Coinbase Prime, easing sell-off fears as BitMine bought $50.6 million in ETH on the dip.
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer ...
One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved ...
The Digital Chamber, a crypto advocacy organization with over 250 members, has escalated a coordinated lobbying campaign urging the U.S. Senate to pass the Digital Asset Market Clarity Act (CLARITY ...
Tonight, the renaissance of Art Garfunkel continued as the Rock & Roll Hall of Fame inductee, eight-time Grammy Award winner, ...
From May 25 to 29, 2026, the 7th China–CEEC Local Leaders' Meeting and 2026 Shandong International Friendship Cities ...
Archer Aviation (NYSE:ACHR) has completed Phase 3 of 4 in the FAA Type Certification process for its Midnight eVTOL aircraft. The company is the first eVTOL manufacturer to reach this stage of ...
Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results